This week, we will discuss a NEJM trial on uncontrolled hypertension: lorundrostat, an aldosterone synthase inhibitor, aims at the hormonal dark side driving resistance.
Does Lorundrostat Effectively Lower Blood Pressure in Uncontrolled Hypertension?
Stunning visual abstract summarizing NEJM study, by Priti Meena
Is a lower BP the road to better outcomes in diabetes?
How low is too low for blood pressure? Will BPROAD get to the bottom of this issue?
Microvascular inflammation of kidney allografts
Microvascular inflammation from the perspective of a real unicorn: donor-specific antibodies with negative antibody mediated rejection 🦄
Kidney Allografts-Play With Fire, Get Burned
REGENCY: A B-Cell Super Destroyer in Lupus
BPROAD: Sprinting down the BP Road in Diabetes
Playing It Safe: Can Felzartamab Fill the Gap in AMR Treatment?
Trial by Combat: Do Amino Acids provide PROTECTION to the Kidneys?
FLOW - El Resumen Visual
¡La Marea de Semaglutida llegó a la Enfermedad Renal Crónica!
Del monstruo de Gila al estudio FLOW.
Para ello, veamos el hermoso resumen visual realizado por la pasante de NephEdC, Anjana Gopal, traducido por Milagros Flores.
FLOW- the Visual Abstract
‘FLOW’ing with the Semaglu’TIDE’!
Check the beautiful visual abstract made by NephEdC intern Anjana Gopal, with an appearance of the Gila monster as well.
